The incidence of depression in new users of beta-blockers and selected antihypertensives

Journal of Clinical Epidemiology

Volumn 49, Issue 7, 1996, Pages 809-815

  Gerstman, B Burt ^a   Jolson, Heidi M ^b   Bauer, Mark ^c   Cho, Pyone ^a   Livingston, James M ^d   Platt, Richard ^d,e  

^a SAN JOSE STATE UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c HARVARD PILGRIM HEALTH CARE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adrenergic receptor blockaders; Ambulatory care; Central nervous system effects; Depression; Hypertension; Information systems; Propranolol

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PROPRANOLOL;

ADULT; ARTICLE; DEPRESSION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK;

EID: 0030197610     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)00017-0     Document Type: Article

References (31)

1. 1. Yudo SC. Beta-blockers and depression. The clinician's dilemma. JAMA 1992; 267: 1826-1827.
2. 2. Burke LB, Baum C, Jolson HM, Kennedy DL. Eleventh Annual Review of Drug Utilization in the United States, 1989. Department of Health and Human Services, Washington, D.C., 1991.
3. 3. Waal HJ. Propranolol-induced depression. Br Med J 1967; 2: 50.
4. 4. Petrie WM, Maffucci RJ, Woosley RL. Propranolol and depression. Am J Psychiatry 1982; 139: 1.
5. 5. Nolan BT. Acute suicidal depression associated with use of timolol. JAMA 1982; 247: 1567.
6. 6. Kalayam B, Shamoian CA. Propranolol, psychoneuroendocrine changes, and depression. Am J Psychiatry 1982; 139: 1374-1375.
7. 7. Patterson JF. Depression associated with enalapril. South Med J 1989; 82: 402-403.
8. 8. McNeil GN, Shaw PK, Dock DS. Substitution of atenolol for propranolol in a case of propranolol-related depression. Am J Psychiatry 1982; 139: 1187-1188.
9. 9. Faber R. Nadolol and antidepressant response. Biol Psychiatry 1983; 18: 1338-1339.
10. 10. Oppenheim G. Propranolol-induced depression: Mechanism and management. Aust NZ Psychiatry 1983; 17: 400-402.
11. 11. Pollack MH, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: Three cases and a review. J Nerv Ment Dis 1985; 173: 118-119.
12. 12. Cremona-Barbara A. Propranolol and depression. Lancet 1983; 1: 185.
13. 13. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986; 255: 357-360.
14. 14. Patten SB. Propranolol and depression: Evidence from the antihypertensive trials. Can J Psychiatry 1990; 35: 257-259.
15. 15. Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med 1990; 150: 2286-2290.
16. 16. Bright RA, Everitt DE. β-Blockers and depression. Evidence against an association. JAMA 1992; 267: 1783-1787.
17. 17. Bartels D, Glasser M, Wang A, Swanson P. Association between depression and propranolol use in ambulatory patients. Clin Pharmacol 1988; 7: 146-150.
18. 18. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med 1987; 83: 223-229.
19. 19. Prisant LM, Spruill WJ, Fincham JE, Wade WE, Carr AA, Adams MA. Depression associated with antihypertensive drugs. J Fam Pract 1991; 33: 481-485.
20. 20. Schleifer SJ, Slater WR, Macari-Hinson MM, et al. Digitalis and beta-blocking agents: Effects on depression following myocardial infarction. Am Heart J 1991; 121: 1397-1402.
21. 21. Stoudemire A, Brown JR, Harris RT, et al. Propranolol and depression: A reevaluation based on a pilot clinical trial. Psychiatr Med 1984; 2: 211-218.
22. 22. Sorgi P, Ratey J, Knoedler D, Arnold W, Cole L. Depression during treatment with beta-blockers: Results from a double-blind placebo-controlled study. J Neuropsychiatry Clin Neurosci 1992; 4: 187-189.
23. 23. Westerlund A. Central nervous system side effects with hydrophilic and lipophilic beta-blockers. Eur J Clin Pharmacol 1985; 28: 73-76.
24. 24. Conant J, Engler R, Janowsky D, Maisel A, Gilpin E, LeWinter M. Central nervous system side effects of β-adrenergic blocking agents with high and low lipid solubility. J Cardiovasc Pharm 1989; 13; 656-661.
25. 25. Barnett GO, Justice NS, Somand ME, et al. COSTAR - a computer based medical information system for ambulatory care. Proc IEEE 1979; 67: 1226-1237.
26. 26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. (revised). American Psychiatric Association, Washington, D.C., 1987.
27. 27. Rosner B. Fundamental of Biostatistics, 3rd Ed. PWS-Kent Publishing Company, Boston, 1990.
28. 28. Guess HA, Lydick EG, Small RD, Miller LP. Exact binomial confidence intervals for the relative risk in follow-up studies with sparsely stratified incidence density data. Am J Epidemiol 1987; 125: 340-347.
29. 29. Brown CC, Green SB. Additional power computations for designing comparative Poisson trials. Am J Epidemiol 1982; 115: 752-758.
30. 30. Eaton WW, Kramer M, Anthony JC, et al. The incidence of specific DIS/DSM-III mental disorders: Data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand 1989; 79: 163-178.
31. 31. Day E, Maddern L, Wood D. Ausculation of foetal heart rate: An assessment of its error and significance. Br Med J 1968; 4: 422-424.